다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Regencell Bioscience Holdings Ltd (RGC)
Regencell Bioscience Holdings Ltd (RGC) 뉴스

RGC

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RGC

일자	시간	출처	헤드라인	심볼	기업
2024/01/02	20:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/12/15	20:09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/10/28	05:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/06/16	05:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/06/05	19:07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/03/17	19:04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/02/28	23:16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2023/01/04	22:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/12/22	21:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/11/01	05:18	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/09/12	22:18	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/09/12	22:15	Business Wire	Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/07/26	21:34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/06/08	00:37	ValueWalk	Game-Stop Or Game-On? RGC Has It All And Twice More	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/06/03	05:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/18	21:05	Business Wire	Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/18	20:58	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/16	21:56	Business Wire	Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/16	20:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/16	20:00	Business Wire	Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/05/16	19:51	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/04/26	21:08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2022/04/04	20:31	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/12/31	06:06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/12/15	23:49	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/12/13	22:31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/11/18	07:01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/10/29	21:32	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/09/08	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd
2021/09/02	05:21	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:RGC	Regencell Bioscience Holdings Ltd

검색 관련기사 보기:NASDAQ:RGC

Invesco QQQ Trust Series 1

Bank of America

Verizon Communications

US Dollar vs Euro

Health Care Select Sector

American Express

Gold vs US Dollar

BNP Paribas (QX)

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관